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Abstract
The liver is a common host organ for cancer, either through lesions that arise in liver epithelial cells [e.g., hepatocellular 
carcinoma (HCC)] or as a site of metastasis by tumors arising in other organs (e.g., colorectal cancer). However, the changes 
that occur in liver stromal cells in response to cancer have not been fully characterized, nor has it been determined whether 
the different sources of liver cancer induce distinct stromal changes. Here, we performed single-cell profiling of liver stromal 
cells from mouse models of induced spontaneous liver cancer or implanted colorectal liver metastases, with a focus on tumor 
endothelial cells (ECs). While ECs in liver tissue adjacent to cancerous lesions (so-called adjacent normal) corresponded to 
liver zonation phenotypes, their transcriptomes were also clearly altered by the presence of a tumor. In comparison, tumor EC 
transcriptomes show stronger similarities to venous than sinusoidal ECs. Further, tumor ECs, independent of tumor origin, 
formed distinct clusters displaying conserved “tip-like” or “stalk-like” characteristics, similar to ECs from subcutaneous 
tumors. However, they also carried liver-specific signatures found in normal liver ECs, suggesting an influence of the host 
organ on tumor ECs. Our results document gene expression signatures in ECs in liver cancer and show that the host organ, 
and not the site of tumor origin (liver versus colorectal), is a primary determinant of EC phenotype. In addition, primarily 
in tumors, we further defined a cluster of chimeric cells that expressed both myeloid and endothelial cell markers and might 
play a role in tumor angiogenesis.
Keywords Single cell transcriptome · Endothelial cell heterogeneity · Kupffer cells · Adjacentnormal tissue · Liver tumor 
endothelial cells
Introduction
The liver is a common host organ for cancer. Tumors in the 
liver occur either spontaneously through lesions that arise 
in liver epithelial cells (e.g., hepatocellular and cholangio-
carcinomas), or by metastatic spread from primary tumors 
in other organs (e.g., colorectal cancer). Even though tumors 
in the liver are quite common, the changes that occur in 
liver stromal cells in response to tumors have not been well 
characterized. Neither has it been determined whether the 
different cancer types in the liver induce distinct stromal 
changes.
Studies using single cell transcriptome profiling in vari-
ous tumor types have revealed extensive heterogeneity in 
tumor cells and tumor-associated stromal cells, including 
endothelial cells (ECs), fibroblasts, smooth muscle cells 
and immune cells [1–3]. The extent and composition of 
this heterogeneity is thought to be shaped by interactions 
with other cells in the tumor mass [1, 2], and could thus 
be affected by various factors beyond the tumor type. For 
example, it was shown that malignant cells primarily clus-
tered based on their original tumor identity, whereas non-
malignant stromal cells in the tumor mass predominantly 
clustered based on their cell type [4, 5], suggesting shared 
properties within stromal cells across tumor samples of 
the same cancer type. In addition, a comprehensive analy-
sis of bulk RNA profiling from tumor, adjacent normal, 
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and naïve (non-tumor-bearing) tissue, using the GTEx and 
TCGA datasets, revealed that so-called normal adjacent 
tissue presents an intermediate state between naïve/healthy 
and tumor [6], suggesting a strong effect of a tumor on the 
non-tumor portion of the organ.
We previously employed single-cell transcriptome pro-
filing to characterize tumor angiogenesis and EC hetero-
geneity compared to normal ECs [1]. Our findings better 
defined the heterogeneity of ECs in tumors, but these stud-
ies were limited to subcutaneous (s.c.) tumors, and thus 
did not provide information on how the host organ could 
affect the molecular signature. Another limitation of those 
studies was that the choice of normal tissue (heart) was not 
the naïve normal or adjacent-normal tissue corresponding 
to the subcutaneous space where the tumors were grown.
Here we performed single cell profiling of murine liver 
stromal cells in response to both an inducible liver cancer 
and to colorectal cancer metastases, with a focus on tumor 
ECs. In normal liver, we found distinct transcriptomes in 
EC subpopulations according to liver zonation. In liver 
tissue adjacent to cancerous lesions (so-called adjacent 
normal), the liver EC transcriptome was influenced by 
the tumor. Intrahepatic tumor ECs from inducible liver 
cancer and colorectal cancer metastases showed a high 
gene signature overlap with portal vein ECs and displayed 
gene signatures that resembled those found previously in 
subcutaneous tumors, including markers for “tip-like” 
and “stalk-like” endothelial cells. However, they also car-
ried liver-specific signatures found in normal liver ECs, 
suggesting a strong influence of the host organ on tumor 
ECs. Additionally, we detected a cluster of chimeric cells, 
primarily in tumors, that expressed both myeloid and 
endothelial cell markers.
Results
Single cell profiling of endothelial cells (ECs) 
from normal liver
To gain baseline information on liver ECs, we performed 
single cell transcriptome profiling on naïve normal liver 
from immune-competent C57BL/6 and immune-deficient 
SCID (C.B-17 scid) mice. Our single cell data were 
derived from multiple 10× Genomics sequencing runs. 
We benchmarked and observed that batch effect was mini-
mal and rarely impacted cell clustering result (see method 
section for more info on minimization and monitoring of 
batch effect). A total of 1446 cells from normal C57BL/6 
mouse livers were mapped into ten clusters representative 
of various leukocyte cell types (cluster 1–6), epithelial 
cells (cluster 7) and ECs (cluster 0, 8–9) (Fig. 1a and Sup-
plementary Fig. 1a–c). Further, re-clustering of 471 ECs 
identified five subpopulations within the EC population 
(Fig. 1b and Supplemental Table 1). Consistent with the 
structure of the liver vasculature, we were able to annotate 
these subpopulations with consensus markers as central 
vein (CV) ECs (cluster 2, using Rspo3 as a marker) [7], 
sinusoidal ECs (SEC) (cluster 0, 1 and 3, using Clec4g 
as a marker) [8, 9] and portal vein (PV) ECs (cluster 4) 
(Fig. 1c). Using gene expression patterns across subpop-
ulations together with a few well-established EC zona-
tion markers such as Rspo3 and Bmp2, we were able to 
spatially assign the three SEC clusters along the PV to 
CV axis, representing EC zonation (Fig. 1c). Analysis of 
single cells collected from normal livers of naïve SCID 
mice aligned with our findings from C57BL/6 mice regard-
ing EC subpopulations and subpopulation-specific marker 
genes (Supplementary Fig. 1d–e).
To assess whether there are mouse strain-specific differ-
ences in naïve liver ECs, we performed cell clustering on 
combined ECs from C57BL/6 and SCID livers (Fig. 1d). 
ECs from C57BL/6 and SCID mice aggregated into the 
same CV or PV clusters (cluster 3 and 4, respectively) 
(Fig. 1d and Supplementary Fig. 2a). However, within 
each CV or PV cluster, ECs segregated by strain. Sinu-
soidal ECs were again classified into three clusters, which 
also sub-segregated by strain: one cluster (cluster 2) was 
SCID-derived, whereas the other two clusters (cluster 0, 
1) were from C57BL/6 mice. Strain-specific genes were 
found in liver ECs (Supplemental Table 1 and Supple-
mentary Fig. 2b) with more differentially detected genes 
in SEC than PV or CV, due to higher SEC cell counts. 
Functional enrichment analyses of these differential genes 
showed that genes highly expressed in SECs of C57BL/6 
mice were significantly associated with immune-related 
pathways, such as antigen presentation and process-
ing, complement cascade and hematopoietic cell line-
age (Fig. 1e). For example, expression of genes involved 
in MHC class II antigen presentation including Cd74, 
H2-Ab1, Ctsb, and Lgmn were significantly higher in SECs 
derived from immune-competent mice (C57BL/6) com-
pared to SCIDs. On the other hand, genes more highly 
expressed in the sinusoidal ECs of SCID mice showed 
enrichment in ribosomal genes and oxidative phosphoryla-
tion. These findings suggested that the immune status may 
contribute to the transcriptional profile of liver ECs.
To benchmark the EC subpopulation and zonation genes 
derived from this study, we compared the results to recently 
published human [10] and mouse [8] studies. While the 
conservation of zonation genes was limited between mouse 
and human liver ECs, a number of reported mouse liver EC 
zonation profiles [8] did exhibit similar zonation patterns in 
our dataset, such as Sox17 and Dll4 as periportal EC markers 
(Supplementary Fig. 2c). However, the expression patterns 
of many reported zonation genes [8] were not reproduced in 
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our current study. To further validate our zonation findings, 
we performed RNAScope for validation of marker expres-
sion in the respective specialized liver vessel structures. As 
expected Rspo3 was highly expressed in the CV [7] (Sup-
plementary Fig. 2d). Additionally, we were able to confirm 
Selp as another CV-enriched gene and Nrg1 as a PV-specific 
gene (Fig. 1f).
Intrahepatic tumor ECs formed a distinct 
subpopulation, and adjacent normal ECs were 
affected by the presence of tumor
To induce liver cancer in situ in immune-competent mice, 
we employed a hydrodynamic delivery (HDD) approach tar-
geting oncogenic pathways in hepatocytes. Activated Kras 
(mKrasG12D) and deletion of p53 (CRISPR-sgTrp53) were 
delivered to immune-competent C57BL/6 and BALB/c mice 
as well as immune-compromised SCID mice, via HDD of 
plasmid DNA. Mice subjected to HDD developed multi-
ple tumors throughout the liver. Histological examination 
of these tumors revealed a mixed hepatocellular/cholangio-
carcinoma phenotype (Fig. 2a), similar to what has been 
reported in some liver cancer patients [11]. Certain tumor 
regions showed a solid trabecular structure, as typically 
observed in human hepatocellular carcinoma, whereas other 
regions displayed bile duct differentiation features, as evi-
denced by the positive staining for cytokeratin 19, and fea-
tured a Masson-positive stromal reaction, similar to human 
cholangiocarcinoma. Tumor-bearing livers were either 
used undissected (resulting in a mix of cells from tumor 
and adjacent normal tissue) or dissected macroscopically 
into tumor and adjacent normal tissue. It is noteworthy that 
the dissected adjacent normal portion of a liver might have 
contained small tumors that were not visible by gross inspec-
tion. Similarly, dissected tumor tissue might have contained 
small portions of adjacent normal tissue.
When comparing ECs from HDD-induced liver tumors to 
those from normal liver, we initially focused on one strain 
of immune-competent mice. A total of 356 single ECs from 
tumors or adjacent normal tissues of C57BL/6 mice were 
identified and combined with the previously collected 471 
ECs from naïve normal liver for cell-clustering analyses 
(Fig. 2b). As previously, ECs from CV and PV formed 
distinct clusters (cluster 3 and 4), but cells segregated by 
sample type within the CV cluster. Sinusoidal ECs were 
separated into two clusters: one cluster (cluster 0) predomi-
nantly composed of cells from naïve normal liver; the other 
(cluster 1) mainly composed of cells from tumor-adjacent 
normal liver. ECs from liver tumors formed a distinct clus-
ter (cluster 2). Examination of cluster-specific marker genes 
showed that tumor ECs expressed a unique set of genes 
such as Col18a1 and Aplnr, but also shared a number of 
expressed genes with venous ECs, especially with PV, such 
as Cd63, Ehd4, and Cd200 (Fig. 2c and d, Supplementary 
Fig. 3a, and Supplementary Table 2). In contrast, tumor EC 
transcriptomes showed minimal overlap with sinusoidal EC 
transcriptomes. As previously reported, significantly higher 
numbers of genes were detected in tumor ECs than normal 
ECs (Fig. 2e) [12]. Genes preferentially expressed by tumor 
ECs were enriched in functions including angiogenesis, cell 
proliferation, cell-cell adhesion, and response to cytokines 
(Fig. 2f).
To determine whether the presence of an adaptive 
immune system affected the pattern of tumor EC gene 
expression, HDD-induced liver tumors from immune-defi-
cient SCID mice were also profiled. As seen in immune-
competent mice, a distinct cluster of tumor ECs was 
observed in HDD-induced tumors in SCID mice, along with 
similar tumor EC-specific genes and their associated func-
tions (Supplementary Fig. 3b–d).
Many gene expression differences were observed between 
naïve liver and so-called adjacent normal liver tissue, sug-
gesting that the tumor influenced the transcriptome of adja-
cent normal stromal cells including ECs. For example, Selp 
was increased in SECs and induced in PV from tumor-bear-
ing livers. This result was supported by RNAScope findings 
(Figs. 1f and 2d). Another molecule Lrg1, a mitogen demon-
strated to promote angiogenesis in the presence of TGF-β1 
[13], was highly expressed in tumor ECs and upregulated in 
adjacent normal ECs (Fig. 2g). The presence of tumor also 
induced upregulation of Sema3d, which encodes the ligand 
for plexin D1 and is involved in angiogenesis, in adjacent 
normal ECs (Fig. 2g). We also observed that the transcrip-
tome alterations in tumor-adjacent normal vs. naïve normal 
liver differed between C57BL/6 and SCID mice (Supple-
mentary Table 2), although there was overlap in certain dif-
ferential genes. For example, upregulation of Serpina3h was 
only observed in the liver SECs of C57BL/6 mice (Fig. 2c). 
With the same cutoffs applied, a lower number of differen-
tial genes between adjacent normal and naïve normal liver 
were detected in CV ECs compared to SECs (Supplementary 
Table 2). However, there were fewer CV and PV cells than 
SECs, which limited the power of this type of analysis. In 
summary, the presence of a liver tumor led to transcriptome 
changes in ECs of the adjacent normal liver region.
Minimal impact of host immune status on tumor EC 
transcriptome
Since normal ECs from C57BL/6 and SCID mice showed 
substantial transcriptional differences, we combined ECs 
derived from both tumor-bearing and normal (naïve and 
adjacent normal) livers from C57BL/6, BALB/c and SCID 
mice and re-performed cell clustering (Fig. 3). Over 1600 
ECs clustered primarily based on EC subtypes, such as clus-
ter 2 and 4 representing CV and PV ECs, respectively. SECs 
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roughly formed three clusters representing sinusoids from 
naïve normal C57BL/6, naïve normal SCID, and adjacent 
normal liver tissues from all three mouse strains (Fig. 3a–c). 
Again, tumor ECs collectively formed a distinct cluster 
(Fig. 3b). Within the tumor EC cluster, cells from differ-
ent strain backgrounds mixed well and did not display dis-
parity (Fig. 3c). Nevertheless, we queried for differentially 
expressed genes in tumor ECs between immune-competent 
(C57BL/6 or BALB/c) and immune-compromised (SCID) 
strains and found only a few genes with significant scores 
(adjusted P value < 0.01 and fold change > 2) (Fig. 3d and 
Supplementary Table 2). Additionally, fewer genes over-
lapped between the two comparison results. Thus, it is rea-
sonable to conclude that intrahepatic tumor ECs were mini-
mally impacted by immune status of the host tissue.
Minimal impact of intrahepatic tumor type 
on tumor EC transcriptome
To determine whether the tumor type affects tumor EC 
phenotype, we utilized a second intrahepatic tumor model, 
where human HT-29 colorectal cancer cells, which we 
used previously for s.c. tumor studies [1], were implanted 
directly into the liver parenchyma. Such a model has been 
used to represent metastatic colorectal cancer [14]. Intra-
hepatic HT-29 tumors grew as a single mass in the liver 
and displayed features of a well differentiated CRC, as evi-
denced by neoplastic cells with a glandular differentiation 
and mucinous material in the glandular lumens, as well as a 
prominent stromal compartment (Supplementary Fig. 4a). 
To increase the power of the analysis, ECs from all sample 
collections including naïve normal liver, adjacent normal 
liver, and intrahepatic HDD-derived and HT-29 tumors were 
merged and subsequently clustered into nine subpopulations 
(Fig. 4a). At first glance, two clusters stood out because they 
were almost exclusively composed of cells from tumors 
(Fig. 4b). Therefore, these clusters were designated as tumor 
ECs. While CV- and PV-derived ECs showed one distinct 
cluster each, the SEC subpopulation was further divided into 
three clusters despite a shared common gene signature: one 
cluster was almost exclusively comprised of cells from naïve 
livers (only collected from C57BL/6 and SCID mice), which 
was named sinusoid.naïve, one cluster mainly contained ECs 
from tumor-bearing livers (adjacent normal or mix) and 
thus named sinusoid.adjacent, and one cluster designated 
as sinusoid.intermix contained cells from both naïve and 
tumor-bearing livers (Fig. 4a). Additionally, two new distinct 
clusters emerged. They were annotated as arterial ECs and 
lymphatics based on known marker genes (Fig. 4a left). For 
example, Stmn2 and Sox17 were expressed in arterial cells 
[1] and Mmrn1 and Pdpn are lymphatic-specific [1]. We 
further validated lymphatic-specific expression of Tbx1 by 
RNAScope (Supplementary Fig. 4b). Lymphatic ECs, which 
were mostly tumor-associated (Fig. 4b), showed a higher 
gene count per cell (Fig. 4c) than ECs from normal liver.
The cumulative 506 tumor ECs derived from intrahepatic 
tumors (HDD-induced and HT-29 tumors) separated into two 
distinct subpopulations (Fig. 4a). The top subpopulation-
specific genes in clusters tumor.EC1 and tumor.EC2 highly 
overlapped with those previously identified as “tip-like” and 
“stalk-like” EC marker genes in s.c. tumors, respectively 
(Fig. 4d) [1]. For example, Dll4 and Notch4 expression was 
limited to tip-like cells, Tgfbr3 was expressed in stalk-like 
cells, while both EC populations expressed similar levels of 
Kdr (Vegfr2) (Supplementary Fig. 4c).
Within the two tumor EC clusters, cells from various 
mouse strains and tumor types (mouse and human tumors) 
were well-intermixed in the t-SNE plot (Fig. 4b). Focus-
ing on only SCID mice, we further checked gene expres-
sion differences in tumor ECs between HDD-derived and 
transplanted HT-29 intrahepatic tumors. Only a few genes 
showed preferential expression in one or the other intrahe-
patic tumor model (Supplemental Fig. 4d). Thus, the tumor 
type exerted minimal influence on the tumor EC transcrip-
tome profiles in liver.
Integrated analysis of normal and tumor ECs from different 
organs
The clear separation of tumor ECs from naïve/adjacent normal 
ECs, and the observed conservation of tip- and stalk-like gene 
signatures in tumor ECs from s.c. and liver tumors, prompted 
us to look for commonalities that could serve as tumor EC-
specific markers. Consequently, we performed an integrated 
analysis by combining our liver and heart [1] data with pub-
lished single cell data on ECs from normal mouse tissues 
Fig. 1  Molecular heterogeneity of endothelial cells (ECs) in normal 
liver. a Left, t-SNE plot showing clusters identified from 1,446 cells 
collected from normal C57BL/6 mouse liver tissue. Right, expression 
of cell-type marker genes in the t-SNE plot. Expression level UMI in 
natural log scale: blue, high; gray, low. b Further clustering of ECs 
in the C57BL/6 normal liver. Five subpopulations detected including 
sinusoid (clusters 0, 1 and 3), central vein (CV, cluster 2) and portal 
vein (PV, cluster 4). c Upper, heatmap of EC subpopulation-specific 
genes. Liver EC subpopulations are arranged in a zonation order from 
PV to CV based on a few well-established zonation markers such as 
Rspo3, Wnt2 and Msr1 etc. The numbers below in the heatmap cor-
respond to cluster numbers as in 1b. Asterisk, two genes chosen to 
be validated by RNAScope (see 1f). Lower, expression profile (mean 
UMI within the cluster) of selected zonation genes by line plot 
linking points representing five clusters in the same order as in the 
heatmap above. d t-SNE plot of combined normal liver ECs from 
C57BL/6 and SCID mice. Left, colored by identified clusters; Right, 
colored by strain background. e Functional enrichment of genes pref-
erentially expressed in liver sinusoid of C57BL/6 compared to SCID 
mice. f RNAScope validation of a novel central vein marker (Selp) 
and a novel portal vein marker (Nrg1) in normal liver from SCID 
mice. CV, central vein; PV, portal vein; SEC, sinusoid endothelial 
cells
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including lung [15] and kidney [16] obtained using compa-
rable single-cell sequencing techniques. Even when sequence 
read coverages in ECs from different sources were compa-
rable, the number of genes detected could vary significantly 
(Supplementary Fig. 5a). ECs from different normal organs 
(heart, lung, kidney, liver) clustered based on tissue of origin 
(Fig. 5a). Most normal organs further displayed EC subpopu-
lations, such as liver (cluster 0, 2, 4, 11), kidney (cluster 7, 8) 
and lung (cluster 5, 9), whereas heart ECs formed one cluster 
(cluster 1) at the applied clustering resolution. At the applied 
cluster resolution, lymphatic ECs from heart and liver mapped 
into one cluster (cluster 10), indicating substantial similarity, 
which was further supported by a high-correlation coefficient 
score in transcriptome (Supplemental Fig. 5b). Tumor ECs 
clustered away from normal ECs. Despite conservation of tip- 
and stalk-like genes, s.c. tumor ECs formed a separate cluster 
(cluster 3) from intrahepatic tumor ECs (cluster 6).
Because the ECs in the combined analysis above were 
pooled from different sources, batch effects should not be 
Fig. 2  Distinct tumor EC and adjacent normal EC subpopulations in 
tumor-bearing liver tissues. a Characterization of HDD-induced intra-
hepatic tumors. (a) Gross image of liver harboring multiple HDD-
induced tumors. Histological features of HDD-induced tumors by 
H&E (b), Masson Trichrome (c) and keratin 19 (Krt19) RNAScope 
(d) at × 20 magnification. b t-SNE plot of combined ECs collected 
from normal liver, dissected tumor, tumor-adjacent normal and undis-
sected tumor-bearing liver (tumor and adjacent normal combined) 
tissue from C57BL/6 mice. Left, single cells colored by identified 
clusters; Right, cells colored by sample type. Bottom, nomenclature 
of sample types. c Heatmap of top 15 EC cluster-specific genes. Clus-
ters (corresponding to the t-SNE plot in 2b) were annotated based 
on both known EC marker genes and sample type. d RNAScope on 
intrahepatic tumors and adjacent normal liver tissues of SCID mice 
showing tumor-specific expression of Aplnr and upregulation of Selp 
in sinusoid and PV (see naïve normal tissue expression in Fig.  1f 
for comparison). Pecam1 was used as pan-EC marker. e. Gene and 
UMI counts across clusters (corresponding to t-SNE plot in 2b). f 
Functional enrichment (GO terms) of genes preferentially expressed 
(upregulated) in tumor ECs compared to non-tumor liver ECs. g Fea-
ture plot showing upregulation of Lrg1 and Sema3d in adjacent nor-








































































Fig. 3  Tumor ECs derived from HDD-induced liver tumors of vari-
ous genetic backgrounds were intermixed. a t-SNE plot of combined 
endothelial single cells collected from tumor-bearing and naïve liver 
tissues from C57BL/6, BALB/c and SCID mice. Cells are colored by 
identified clusters which were annotated by markers, sample type and 
strain information. b Left, t-SNE plot shown in 3a colored by sam-
ple type; Right, percentage of cell contribution from different sam-
ple types. c t-SNE plot shown in 3a colored by mouse strain. Liver 
tumor ECs grown in different mouse strains form one distinct cluster 
and were well-intermixed within the cluster. d Violin plot showing 
expression of select differentially expressed genes in tumor ECs from 
immune-competent and immune-compromised mice
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ignored. However, because ECs in the s.c. tumor cluster 
(cluster 3) were collected from different xenograft models 
and were profiled in separate 10× Genomics single cell runs, 
the most influential factor on EC transcriptome appears to be 
the host tissue. Each cluster displayed distinct tissue-specific 
and subpopulation-specific gene signatures (Fig. 5b), which 
were deprived of the usual batch-related genes such as Jund, 
Klf and ribosomal genes. Although common tumor EC genes 
such as Nid2 and Col15a1, were detected in s.c. and liver 
tumor-derived ECs, two distinct clusters formed based on 
the site of tumor growth (i.e., s.c. and liver). Collectively, 
ECs express common endothelial lineage markers but also 
carry tissue- and cell state-specific imprints (proliferation, 
metabolism, etc.).
Following up on this observation, we focused on HT-29 
tumors in SCID mice and assessed differentially expressed 
genes in ECs derived from intrahepatically and subcuta-
neously grown tumors. Many genes were preferentially 
expressed in intrahepatic tumor ECs, whereas few genes 
were uniquely expressed in s.c. tumor ECs (Fig.  5b). 
Although the majority of the liver-specific genes appeared 
to be involved in house-keeping functions (Fig. 5c and Sup-
plementary Table 3), there were a number of genes such as 
Tgfb1, Hras, Sumo2 and Sox17 that are involved in cellu-
lar functions beyond housekeeping (Fig. 5d). These results 
showed that the host organ, but not the tumor type, exerted 
significant influence on EC phenotypes in liver tumors. 
Taken together, tumor ECs carry conserved as well as host 
organ-imposed gene signatures.
Chimeric myeloid-endothelial cell type present 
in tumor-bearing livers
When assessing EC marker gene expression in all single 
cells collected from the liver, we noticed that a subpopula-
tion of the Kupffer cell cluster also expressed conventional 
EC marker genes (Supplemental Fig. 6a–c). Based on gene 
and UMI counts, these cells did not appear to be dou-
blets (Supplemental Fig. 6d). In support of the existence 
of chimeric cells, double-positive cells expressing the EC 
marker CD31 (Pecam1) and the Kupffer cell marker Clec4f 
were detected by IHC (Fig. 6a). These cells were often 
detected close to blood vessels without integrating into the 
vessel. To further investigate these cells, we combined all 
Kupffer cells and ECs for re-clustering. Two subpopula-
tions (cluster 7 and 8) emerged between ECs (cluster 0, 2, 
3, 4 and 5) and Kupffer cells (cluster 1 and 6), which dis-
played mixed molecular phenotypes (Fig. 6b). In particu-
lar, cells in cluster 7 expressed a higher number of genes, 
which is often seen in tumor ECs, and were more prevalent 
in tumor-bearing livers than naïve livers (P value < 0.001 
by Fisher Exact test) (Fig. 6c). The host mouse strain did 
not affect the presence of these two populations (Fig. 6c). 
All cells from clusters 7 and 8 expressed EC marker genes, 
such as Pecam1, Clec4g, Rspo3, Egfl7, and Robo4, as well 
as monocyte/macrophage markers, such as Csf1r and C1qa 
(Fig. 6d and Supplementary Fig. 7a).
Furthermore, there were differences between cluster 7 
and 8. In particular, cells in cluster 7 showed preferen-
tial expression of monocyte/macrophage markers F13a1 
and Itgam (Cd11b), whereas cells in cluster 8 expressed 
higher levels of Kupffer cell markers Clec4f and Vsig4 
(Fig. 6d and Supplementary Fig. 7b, c). Further trajectory 
and cluster tree analyses suggested that clusters 7 and 8 
possessed more EC transcriptome properties than Kupffer 
cell properties (Supplementary Fig. 7d). Altogether, this 
led us to name cluster 7 “macrophage-EC” and cluster 8 
“Kupffer-EC”. To further investigate the myeloid signal in 
these chimeric ECs, we first classified all myeloid cell pop-
ulations and subpopulations in our dataset (Supplementary 
Fig. 8 and Supplementary Table 4). Next, we constructed 
a trajectory including all myeloid cells (except plasma-
cytoid dendritic cells, i.e., pDC) and the chimeric ECs, 
which revealed that the “Kupffer-ECs” (red) were most 
closely related to naïve and inflamed Kupffer cells (teal 
and turquoise), whereas the “macrophage-ECs” (pink) 
clustered with macrophages (different shades of blue), 
all of which were located at the same end of the trajec-
tory. A closer look at the EC features of “Kupffer-ECs” 
and “macrophage-ECs” revealed that specific CV and PV 
marker genes described above were barely expressed in 
either subpopulation (Fig. 6d; Rspo3 as an example of a 
CV marker). This observation suggests that chimeric ECs 
represent an intermediate phenotype between Kupffer cells 
or macrophages and sinusoidal ECs.
Discussion
In this study, we performed transcriptome profiling on sin-
gle cells from normal and tumor-bearing livers and stud-
ied endothelial cell heterogeneity at the single-cell level 
Fig. 4  Identification of arterial, lymphatic, tumor tip and stalk sub-
populations by combined analysis of ECs in naïve and tumor-bearing 
liver tissues. a Left, t-SNE plot of ECs derived from naïve normal 
liver, HDD-induced tumor-bearing and HT-29-bearing liver tissues. 
Nine subpopulations were identified and annotated as arterial, CV, 
lymphatics, PV, 3 sinusoids subpopulations, and two tumor EC sub-
populations (tumor.EC1 and tumor EC.2). Right, heatmap of top 8 
subpopulation-specific genes. b. Left, t-SNE plot (corresponding to 
Fig. 4a) colored by sample type or mouse strain; Right, stacked bar 
plot of percentage of contribution by sample type or mouse strain. c. 
Gene and UMI counts across the nine subpopulations (a). d. Heatmap 
of top 15 genes enriched in liver tumor tip-like (n = 373) and stalk-
like (n = 133) EC subpopulations. Red and blue arrows indicate genes 
also identified as tip-like and stalk-like cell markers in s.c. tumors, 
respectively
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(summary of sample collection in Supplemental Table 5). 
We monitored batch effect by performing multiple sequenc-
ing runs on the same sample type and concluded that batch 
effect is of minimal concern and will not affect our conclu-
sions. Analysis of ECs from normal livers revealed zona-
tion-related gene expression patterns along the PV-CV liver 
zonation axis. We also observed that mouse strain affected 
EC gene expression signatures. Our data showed that genes 
highly expressed in SECs of C57BL/6 mice were signifi-
cantly associated with immune-related pathways, such as 
genes involved in MHC class II antigen processing and 
presentation including Cd74, H2-Ab1, Ctsb, and Lgmn, 
which has been related to induction of immune tolerance 
[17]. However, whether the strain-specific genes detected 
in ECs between C57BL/6 and SCID were associated with 
the immune status of the mice needs further experimental 
validation. Despite the fact that a more systematic approach 
is needed to identify and assign relevance to EC gene signa-
tures that are influenced by immune status, our data did pro-
vide some insights into the influence of the mouse immune 
status on myeloid cell populations. For example, subpopula-
tions within macrophages were apparently driven by strain 
differences in a tumor setting. Similarly, it has been reported 
that the immunologic phenotypes of commonly used inbred 
mouse strains, such as BALB/c and C57BL/6, are quite 
divergent when used for tumor studies [18]. This raises the 
question, to what extent these differences affect non-immune 
stromal cells in the TME, such as ECs or fibroblasts.
Tissue samples derived from the non-tumor-bearing 
part of an organ are often used as control material when 
studying changes prevalent in the tumor tissue. However, 
a comprehensive analysis of bulk RNA from tumor, adja-
cent normal, and naïve (non-tumor-bearing organ) tissue 
data from the GTEx and TCGA datasets revealed that so-
called adjacent normal tissue presents an intermediate 
state between naïve/healthy and tumor [6]. Similarly, at 
the single cell level, ECs from adjacent normal tissue in 
tumor-bearing livers had pronounced alterations in tran-
scriptome compared to ECs from naïve livers. These data 
highlight that stromal cells in so-called adjacent normal 
tissue might already harbor tumor-induced changes.
Additional changes in EC phenotypes occurred in the 
actual tumor mass. The arterial and lymphatic EC popula-
tions appeared to expand, since these clusters were mainly 
composed of tumor-derived ECs. These observations were 
in agreement with previous reports that HCC or intrahe-
patic CRC tumors have increased lymphangiogenesis [19, 
20], and that a switch to prominent arterial blood supply 
occurred at the stage of early HCC [21–23]. Interestingly, 
lymphatic ECs expressed a higher number of genes than 
blood vessel EC. In particular, cytokine and chemokine 
receptors were highly upregulated in lymphatic ECs, sug-
gesting a close functional relationship between lymphatic 
ECs and immune cells. Tumor ECs form distinct clusters 
of tip-like and stalk-like endothelial cells, which share sig-
natures with tip-like and stalk-like endothelial cells previ-
ously defined in s.c. tumors, indicating conserved angio-
genic mechanisms during tumor angiogenesis. Notably, 
the influence of tumor type (induced vs. implanted HT-29) 
on tumor ECs was rather limited. Globally, liver tumor 
ECs did not express typical EC markers for SEC (Clec4g) 
and lost classical CV (Rspo3) and PV (Adgrg6) markers. 
However, tumor ECs carried a gene signature related to 
PV ECs (Fig. 2b and c).
Comparison of our single cell transcriptome profiling data 
with previously published EC signatures from normal liver 
and liver tumors revealed significant overlap. For example, 
Seaman et al. [24] identified normal and tumor EC-specific 
signatures in mouse liver tumor models using a SAGE plat-
form on pooled ECs. Halpern et al. [8] used a paired-cell 
sequencing strategy to infer the expression zonation of liver 
ECs. The overlapping gene expression signature between 
these studies support our EC cluster annotation. However, 
the analysis of individual cells in the current study provided 
additional granularity and depth of information not only on 
ECs but also acrosss various other cell types and subtypes 
in tumors.
We identified a set of chimeric myeloid-endothelial cells 
in our study. Upon further resolution, these chimeric cells 
could be classified as either Kupffer-ECs (expressing both 
Kupffer and EC markers) or macrophage-ECs (expressing 
macrophage and EC markers). In our studies, these cells 
were detected at a rate of about five percent (147 out of 2,684 
ECs). Based on strain and sample type distribution com-
pared to other EC cell types, we speculate that the Kupffer-
EC population pre-exists in naïve liver tissue, whereas the 
macrophage-EC population is less common in naïve liver, 
but expands when a tumor is present, since these cells were 
significantly enriched in tumor-associated samples and were 
phenotypically closer to tumor-associated macrophages.
Contributions of bone marrow (BM)-derived progenitor 
cells to the formation of liver sinusoidal vessels have been 
Fig. 5  Comparison of normal and tumor ECs from different host 
organs revealed tissue-specific signatures in ECs. a t-SNE plot of a 
collection of ECs from different normal tissues (liver in this study 
n = 719, heart n = 629, lung n = 401 and kidney n = 386) as well as 
tumors (intrahepatic tumors in this study and s.c. tumors n = 240). 
ECs are colored by clusters (left) or by tissue of origin and tumor 
types (right). b Heatmap showing top 10 cluster-enriched genes in 
different subpopulations (as in 5a). Gene signatures distinctive to 
tumor ECs are highlighted by dashed boxes. c Functions enriched 
in genes preferentially expressed by intrahepatic HT-29 tumor ECs 
compared to s.c. HT-29 tumor ECs. d Violin plots showing conserved 
tumor EC genes (Aplnr and Kcne3) with similar expression levels in 
intrahepatic and s.c. HT29 tumors and genes exclusively expressed in 
intrahepatic HT-29 tumor ECs (Tgfb1, Sumo2, Hras, Sox17)
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reported in liver transplantation experiments under varied 
conditions [25–30]. For example, BM-derived mononuclear 
cells were reported to contribute to liver sinusoidal vessels 
after liver EC injury by irradiation, but not during liver 
regeneration after partial hepatectomy in mouse models [28]. 
In other studies, myeloid progenitor cells differentiated into 
sinusoidal EC regardless of liver injury [25]. During liver 
development in embryogenesis, a dual mechanism of vascu-
lar expansion involving proliferation of existing endothelial 
cells as well as incorporation of erythro-myeloid precursors 
has been described [27]. In tumor settings, the contribution 
of BM-derived endothelial progenitor cells to tumor angio-
genesis is less clear [31]: on one hand BM-derived endothe-
lial progenitor cells were reported to contribute to tumor 
angiogenesis in both direct and indirect ways [32], whereas 
other studies showed that the recruited BM-derived cells 
did not play a role in tumor angiogenesis [33, 34]. Results 
from our single cell analyses indicate the macrophage-EC 
population, but not the Kupffer-EC population, is signifi-
cantly enriched in tumor-bearing livers, possibly suggesting 
a role for this cell population in tumor angiogenesis or other 
aspects of the tumor microenvironment.
Previous studies were not able to fully characterize the 
expression profile of these cells, but our application of single 
cell approaches now provides such signatures in an unbiased 
way. One of the EC markers expressed in both Kupffer-ECs 
and macrophage-ECs is Tek/Tie2 (Supplementary Fig. 9), 
which leads us to speculate that these cells represent a rare 
cell population in tumor-bearing mice known as pro-angi-
ogenic, pro-metastatic Tie2-expressing monocytes [35–41] 
also found in HCC-bearing liver tissue [42, 43]. Pucci et al. 
reported that the expression profile of Tie2-expressing 
monocytes clearly indicated a monocyte/macrophage line-
age rather than an EC lineage [40]. In our study, the chimeric 
cells initially clustered with Kupffer cells when all cells in 
the liver were analyzed, but when directly compared with 
only Kupffer cells and ECs (including all EC subpopula-
tions in normal and tumor-bearing livers) using trajectory 
and cluster tree analyses, the chimeric cells displayed more 
similarity to ECs. Further, our data suggest that distinct 
subpopulations of Tie2-expressing myeloid cells, such as 
Tie2-positive Kupffer-ECs and macrophage-ECs in the liver, 
exist. This raises the question whether Tie2-expressing cell 
subpopulations could differentially affect tumor angiogen-
esis and metastasis.
Taken together, our results highlight the commonality 
of tumor ECs across different sites of tumor growth (intra-
hepatic vs. subcutaneous) and across different origins of 
tumors within the liver (induced liver cancer vs. CRC metas-
tases). In addition, our studies further illustrate a clear differ-
ence between naïve and adjacent normal ECs and delineate 




Animal studies were performed in accordance with Regen-
eron’s Institutional Animal Care and Use Committee guide-
lines. HT-29 tumor cells [American Type Culture Collection 
(ATCC)] were authenticated in 2012 using the STR Profile 
Testing by ATCC. Micro-ultrasound (Vevo2100, VisualSon-
ics) was used for image-guided intrahepatic implantation of 
 106 HT-29 cells in Matrigel and longitudinal tumor growth 
monitoring (largest tumor diameter). Tumor-bearing liv-
ers were harvested at 10–30  mm2. For HHD-induced liver 
tumors, 50 µg of plasmids encoding mKras (G12D), Cas9 
and sgTrp53 or mKras (G12D), Cas9 and sgRNA (empty 
vector) were combined and diluted in 0.9% NaCl to a vol-
ume ~ 10% of the mouse body weight and injected into the 
tail vein over six to ten seconds [44]. Tumor-bearing livers 
were harvested when sizeable tumors were present. After 
harvest, tissue was processed for histological analysis and 
single-cell sequencing.
RNAScope and immunohistochemistry
Previously described IHC procedures [45] were used on 
4 µm tissue sections. Specifically, after citrate antigen 
retrieval, sections were exposed to 0.3%  H2O2 in metha-
nol, TNT blocking buffer (Perkin Elmer), primary antibod-
ies (anti-CD31 Ab (ab28364, Abcam), anti-CLEC4F Ab 
(AF2784, R&D Systems)) and detection agents (CD31: 
polymer HRP anti-rabbit followed by opal 520 fluorophore 
amplification reagent (PerkinElmer); CLEC4F: Cy-3 donkey 
anti-goat (Jackson Immuno Research). Nuclear stain: DAPI. 
Fig. 6  Identification and characterization of chimeric ECs in nor-
mal and tumor-bearing liver tissues. a Representative IHC image of 
the pan-EC marker CD31 (green), the Kupffer cell marker Clec4f 
(red) and the nuclear marker DAPI (blue). Top: Compressed z-stack 
(deconvoluted) of confocal image, arrow head indicates double-pos-
itive cell, arrow indicates single-positive vascular structure; Bottom: 
single optical plane with orthogonal view of single channels and 
overlay of double-positive cell. b Combined clustering analysis on 
Kupffer cells and ECs revealed two distinct clusters (7 and 8) between 
ECs and Kupffer cells. c Top, gene and UMI counts per cluster (b); 
Bottom, percent contribution of cells to cluster 7 and 8 by sample 
type and mouse strain, respectively, with exact cell counts next to the 
plot in the same order as in the stacked bar plot. d Violin plots show-
ing that cluster 7 and 8 express Kupffer/macrophage and EC marker 
genes as well as myeloid genes at various levels. The numbers on 
x-axis match to the cluster numbers in the t-SNE plot (b). e Trajec-
tory analysis of all myeloid, Kupffer-EC and macrophage-EC sub-
populations. Kupffer-EC (red) and macrophage-EC (pink) cells are 
highlighted in dashed boxes
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Previously described RNAScope method [1] was used on 4 
µm tissue sections using probes from ACD Bio.
Single cell preparation for sequencing
Naïve and tumor-bearing liver tissues were processed with 
a consistent protocol as described previously [1] with an 
enzymatic collagenase/DNase treatment time of 13 min and 
PharMLyse (BD Biosciences) treatment of 5 min (tumor) 
and 10 min (liver, mix). HT-29 tumor single cell suspen-
sions underwent a tumor cell depletion step as previously 
described [1].
Our single cell data were derived from multiple 10× 
Genomics sequencing runs. To benchmark batch effect 
in our data, each sample type (i.e. cells from naïve liver, 
tumor, adjacent normal or a mix type under certain genetic 
background) was subjected to multiple 10× Genomics runs 
spread across different days. Samples representing various 
samples types were collected on the same day and subse-
quently processed for sequencing. For the same sample type, 
batch effect was barely observed in cell clustering result.
Single‑cell sequencing
Single cells were resuspended in PBS + 0.04% BSA. Cellular 
suspensions (~ 6000 cells) were loaded on a Chromium Sin-
gle cell Instrument (10× Genomics) to generate single cell 
GEMs. Single cell RNA-Seq libraries were prepared using 
version 2 Chromium Single cell 3’ Library, Gel beads & 
Multiplex kit (10× Genomics). Sequencing was performed 
on Illumina NextSeq500 using the following read length: 59 
bp Read1 for transcript read, 14 bp I7 Index for Cell Barcode 
read, 8 bp I5 Index for sample index read, and 10 bp Read2 
for UMI read.
Bioinformatics analysis
Alignment, barcode assignment and UMI counting
The Single Cell Software Cell Ranger Suite version 2 was 
used to perform sample de-multiplexing, barcode processing 
and single-cell gene UMI (unique molecular index) quan-
tification (http://softw are.10xge nomic s.com/singl e-cell/
overv iew/welco me). For single cells derived from HT-29 
tumors, reads were mapped to both mouse and human 
genomes. Mouse cells were separated from human cells 
(HT-29 tumor cells) by preponderance of reads mapped to 
the mouse genome.
Single-cell RNA-Seq data QC
Mouse single cells were filtered for downstream analysis 
by the following criteria: the number of genes expressed 
(with at least one UMI count) is within a range between 
500 and 6500, and mitochondria content is less than 
twenty percent of the total UMI count. Overall, 27,542 
cells passed the QC steps, with 7449 cells derived from 
BALB/c, 8295 derived from C57BL/6, 5213 derived from 
SCID-HDD, and 6585 derived from SCID-HT-29 strain, 
respectively.
Clustering of cells and identification of cluster-specific 
genes
Mouse single cells from all sequencing batches were com-
bined for the downstream analysis. All clustering analyses 
were done with Seurat v2 [46] (https ://githu b.com/satij alab/
seura t/) package by using from 300 to 500 highly variable 
genes and were displayed in t-distributed stochastic neighbor 
embedding (t-SNE) plots. FindAllMarkers function in Seurat 
was performed to call cell type-specific genes and differen-
tially expressed genes. Top-ranked genes were ordered by 
fold change under a threshold of adjusted P value < 0.05 
(Bonferroni correction). BuildClusterTree function in Seurat 
2 package was applied to generate cluster trees.
Pseudotime and trajectory maps
The new reconstruction algorithms in Monocle 2 (http://
cole-trapn ell-lab.githu b.io/monoc le-relea se/) was applied 
to single cell trajectory analysis in which cells were placed 
along the pseudotime tree but colored by cell type anno-
tation. Either combined top 50 cell cluster-specific genes 
or top 500 most variable genes were used in building the 
branches, both led to essentially the same branch structure. 
The parameter of max components tested was between 10 
and 12.
Statistical analysis
Conservation between cell types were assessed by Pearson 
correlation of mean UMI on expressed genes in each cell 
subpopulations. Function enrichment analyses on differen-
tially expressed genes were performed using the Database 
for Annotation, Visualization and Integrated Discovery 
(DAVID 6.8, http://david .abcc.ncifc rf.gov). Comparison 
of the distribution of categorical variables in different 
groups was performed with the Fisher exact test using 
two-tailed P values.
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